Table 1.
Postnatal Day | Group | Positive | Negative | Total | % Positive | p Valuea |
---|---|---|---|---|---|---|
14 | control | 25 | 19 | 44 | 56.8% | 0.017 |
miDnm1a | 8 | 21 | 29 | 27.6% | ||
16 | control | 24 | 19 | 43 | 55.8% | 0.156 |
miDnm1a | 11 | 18 | 29 | 37.9% | ||
18 | control | 39 | 3 | 42 | 92.9% | 2 × 10−6 |
miDnm1a | 12 | 17 | 29 | 41.4% | ||
20 | miDnm1a | 5 | 19 | 24 | 20.8% | n.a. |
22 | miDnm1a | 9 | 12 | 21 | 20.8% | n.a. |
24 | miDnm1a | 7 | 13 | 20 | 35.0% | n.a. |
26 | miDnm1a | 3 | 17 | 20 | 15.0% | n.a. |
28 | miDnm1a | 1 | 19 | 20 | 5.0% | n.a. |
30 | miDnm1a | 1 | 19 | 20 | 5.0% | n.a. |
Fisher exact test, two-tail, 2 × 2 contingency analysis. Treated Dnm1Ftfl/Ftfl mice show fewer seizures compared to control-injected Dnm1Ftfl/Ftfl mice, and this is statistically significant at PND 14 and PND 18. At PND 18, four treated mice were removed from the study for histological analysis. n.a. - not applicable.